Position of Teamleader and Leadership Performance
LeadPos
Effect of the Position of the Teamleader on Quality of Leadership and Team Performance
1 other identifier
interventional
151
1 country
1
Brief Summary
Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 22, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedNovember 15, 2022
November 1, 2022
5.3 years
March 22, 2021
November 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantity of leadership
Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire
5 minutes
Secondary Outcomes (2)
Hands-on time
5 minutes
Quality of leadership
5 minutes
Study Arms (2)
Conventional position (head position)
ACTIVE COMPARATORLeaderposition at the patient's head
Remote position
ACTIVE COMPARATORLeaderposition remote from patient and hands-off
Interventions
teamleaders are instructed to allocated position
Eligibility Criteria
You may qualify if:
- Physicians taking part in voluntary workshops
You may not qualify if:
- refusal to participate and/or being videorecorded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Basel, Canton of Basel-City, 4031, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Marsch
University Hospital, Basel, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2021
First Posted
April 1, 2021
Study Start
March 1, 2017
Primary Completion
June 30, 2022
Study Completion
September 30, 2022
Last Updated
November 15, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
Secondary data can be changed Videorecordings of simulations are strictly confidential and cannot be shared